The role of bone morphogenetic proteins in liver fibrosis
Open Access
- 12 February 2021
- journal article
- Published by MedCrave Group Kft. in Gastroenterology & Hepatology: Open Access
- Vol. 12 (1) , 17-20
Abstract
Liver fibrosis is featured by excessive accumulation of extracellular matrix (ECM) proteins in the injury liver of diseases, including alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), cirrhosis, and hepatocellular cancer (HCC). However, there is no current therapy for preventing and reversing liver fibrosis. Transforming growth factor-β1 (TGF-β1) is a key profibrotic gene that drives activation of hepatic stellate cells (HSCs) and their transdifferentiation to myofibroblasts producing ECM proteins. Bone morphogenetic proteins (BMPs) belonging to TGF-β big family play important roles in tissue morphogenesis and homeostasis in the bone, cartilage, muscle, kidney, and blood vessels. Accumulating evidence indicates that BMPs are involved in the development and progression of liver fibrosis and liver regeneration. In this review, we summarize the recent findings of the dual roles of BMPs in liver fibrosis. Strategies have been developed to target these molecules to treat liver fibrosis. However, the efficacy is under expectation. Therefore, better understanding of the underlying mechanisms of BMPs in the progression of liver disease is critically important for improving their therapeutic effect.Keywords
This publication has 12 references indexed in Scilit:
- Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinicAnnals of Hepatology, 2019
- Toward a more accurate estimate of the prevalence of hepatitis C in the United StatesHepatology, 2015
- Treatment with ledipasvir and sofosbuvir improves patient‐reported outcomes: Results from the ION‐1, ‐2, and ‐3 clinical trialsHepatology, 2015
- Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010Annals of Internal Medicine, 2014
- Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?BMC Public Health, 2014
- Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution TherapyClinical Infectious Diseases, 2013
- Hepatitis C in the United StatesNew England Journal of Medicine, 2013
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilitiesEpidemiology and Infection, 2004
- Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver diseaseGut, 1999